778 related articles for article (PubMed ID: 17714124)
1. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
Sanclemente G; Herrera S; Tyring SK; Rady PL; Zuleta JJ; Correa LA; He Q; Wolff JC
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1054-60. PubMed ID: 17714124
[TBL] [Abstract][Full Text] [Related]
2. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
[TBL] [Abstract][Full Text] [Related]
3. Effect of imiquimod in anogenital warts from HIV-positive men.
Herrera S; Correa LA; Wolff JC; Gaviria A; Tyring SK; Sanclemente G
J Clin Virol; 2007 Jul; 39(3):210-4. PubMed ID: 17513167
[TBL] [Abstract][Full Text] [Related]
4. Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men.
Wieland U; Brockmeyer NH; Weissenborn SJ; Hochdorfer B; Stücker M; Swoboda J; Altmeyer P; Pfister H; Kreuter A
Arch Dermatol; 2006 Nov; 142(11):1438-44. PubMed ID: 17116834
[TBL] [Abstract][Full Text] [Related]
5. p16ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in human immunodeficiency virus-infected men and correlates with the decline of lesional high-risk human papillomavirus DNA load.
Kreuter A; Wieland U; Gambichler T; Altmeyer P; Pfister H; Tenner-Racz K; Racz P; Potthoff A; Brockmeyer NH;
Br J Dermatol; 2007 Sep; 157(3):523-30. PubMed ID: 17573882
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men.
Kreuter A; Potthoff A; Brockmeyer NH; Gambichler T; Stücker M; Altmeyer P; Swoboda J; Pfister H; Wieland U;
J Invest Dermatol; 2008 Aug; 128(8):2078-83. PubMed ID: 18273049
[TBL] [Abstract][Full Text] [Related]
7. [Mechanisms of imiquimod indirect antiviral activity].
Hober D; Ajram L; Chehadeh W; Lazrek M; Goffard A; Dewilde A; Wattré P
Ann Biol Clin (Paris); 2005; 63(2):155-63. PubMed ID: 15771973
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus-type predict the clinical outcome of imiquimod therapy for women with vulvar condylomata acuminata.
Dede M; Kubar A; Yenen MC; Alanbay I; Guven S; Mesten Z; Baser I
Acta Obstet Gynecol Scand; 2007; 86(8):968-72. PubMed ID: 17653883
[TBL] [Abstract][Full Text] [Related]
9. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
[TBL] [Abstract][Full Text] [Related]
10. Topical imiquimod treatment of human papillomavirus in a patient with human immunodeficiency virus.
Gilbert J; Drehs MM; Weinberg JM
Acta Derm Venereol; 2001; 81(4):301-2. PubMed ID: 11720183
[No Abstract] [Full Text] [Related]
11. Sinecatechins and imiquimod as proactive sequential therapy of external genital and perianal warts in adults.
Schöfer H; Tatti S; Lynde CW; Skerlev M; Hercogová J; Rotaru M; Ballesteros J; Calzavara-Pinton P
Int J STD AIDS; 2017 Dec; 28(14):1433-1443. PubMed ID: 28566057
[TBL] [Abstract][Full Text] [Related]
12. Anogenital warts and other HPV-associated anogenital lesions in the HIV-positive patient: a systematic review and meta-analysis of the efficacy and safety of interventions assessed in controlled clinical trials.
Werner RN; Westfechtel L; Dressler C; Nast A
Sex Transm Infect; 2017 Dec; 93(8):543-550. PubMed ID: 28637906
[TBL] [Abstract][Full Text] [Related]
13. [Papillomavirus-induced anogenital lesions in 121 HIV seropositive men. Clinical, histological, viral study, and evolution].
Voltz JM; Drobacheff C; Derancourt C; Coumes-Marquet S; Mougin C; Laurent R
Ann Dermatol Venereol; 1999 May; 126(5):424-9. PubMed ID: 10434106
[TBL] [Abstract][Full Text] [Related]
14. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
Gilson R; Nugent D; Bennett K; Doré CJ; Murray ML; Meadows J; Haddow LJ; Lacey C; Sandmann F; Jit M; Soldan K; Tetlow M; Caverly E; Nathan M; Copas AJ
Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
[TBL] [Abstract][Full Text] [Related]
15. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
Park IU; Introcaso C; Dunne EF
Clin Infect Dis; 2015 Dec; 61 Suppl 8():S849-55. PubMed ID: 26602622
[TBL] [Abstract][Full Text] [Related]
16. High-grade Dysplasia in Anogenital Warts of HIV-Positive Men.
Kreuter A; Siorokos C; Oellig F; Silling S; Pfister H; Wieland U
JAMA Dermatol; 2016 Nov; 152(11):1225-1230. PubMed ID: 27463201
[TBL] [Abstract][Full Text] [Related]
17. Intralesional injection of Mycobacterium w vaccine vs imiquimod, 5%, cream in patients with anogenital warts: a randomized clinical trial.
Kumar P; Dar L; Saldiwal S; Varma S; Datt Upadhyay A; Talwar D; Sharma VK; Verma KK; Dwivedi SN; Raj R; Gupta S
JAMA Dermatol; 2014 Oct; 150(10):1072-8. PubMed ID: 25103148
[TBL] [Abstract][Full Text] [Related]
18. Self-administered topical imiquimod treatment of vulvar intraepithelial neoplasia. A report of four cases.
Davis G; Wentworth J; Richard J
J Reprod Med; 2000 Aug; 45(8):619-23. PubMed ID: 10986679
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of HPV-associated Anal Lesions in HIV-positive Patients - Comparison of Surgical Treatment and Topical Therapy with Imiquimod].
Websky MWV; Wesselmann PC; Schwarze-Zander C; Vilz TO; Stoffels B; Boesecke C; Rockstroh J; Kalff JC; Pantelis D
Zentralbl Chir; 2019 Aug; 144(4):349-354. PubMed ID: 29969823
[TBL] [Abstract][Full Text] [Related]
20. [Topical imiquimod cream in the treatment of external anogenital warts: personal experience].
Senatori R; Dionisi B; Lippa P; Inghirami P
Minerva Ginecol; 2003 Dec; 55(6):541-6. PubMed ID: 14676745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
